Las infecciones fúngicas: una amenaza creciente

Beatriz L. Gómez, Patricia Escandón, .

Palabras clave: Micosis


Los datos de descargas todavía no están disponibles.
  • Beatriz L. Gómez Grupo de Estudios en Microbiología Translacional y Enfermedades Emergentes (MICROS), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, D.C., Colombia
  • Patricia Escandón Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, D.C., Colombia

Referencias bibliográficas

Casadevall A. Fungal Diseases in the 21st Century: The near and far horizons. Pathog Immun. 2018;3:183-96.

Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases – estimate precision. J Fungi (Basel). 2017;3:57.

Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: Human fungal infections. Sci Transl Med. 2012;4:165rv13.

Rodrigues ML, Albuquerque PC. Searching for a change: The need for increased support for public health and research on fungal diseases. PLoS Negl Trop Dis. 2018;12:e0006479.

World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. 2022. Fecha de consulta: 15 de agosto de 2023. Disponible en:

Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64:134-40.

Smith DFQ, Casadevall A. Disaster microbiology-a new field of study. mBio. 2022;13:e0168022.

Casadevall A. Don’t forget the fungi when considering global catastrophic biorisks. Health Secur. 2017;15:341-2.

Garcia-Solache MA, Casadevall A. Global warming will bring new fungal diseases for mammals. MBio. 2010;1.

Wu X, Lu Y, Zhou S, Chen L, Xu B. Impact of climate change on human infectious diseases: Empirical evidence and human adaptation. Environ Int. 2016;86:1423.

Nnadi NE, Carter DA. Climate change and the emergence of fungal pathogens. PLoS Pathog. 2021;17:e1009503.

Frías-de-Leon MG, Brunner-Mendoza C, Reyes-Montes M del R, Duarte-Escalante E, editors. The impact of climate change on fungal diseases. New York: Springer International Publishing. 2022.

O’Neill, J. Tackling drug-resistant infections globally: Final report and recommendations. Government of the United Kingdom. 2022. Available from:

Gow NAR, Johnson C, Berman J, Coste AT, Cuomo CA, Perlin DS, et al. The importance of antimicrobial resistance in medical mycology. Nat Commun. 2022:12;13:5352.

Denning DW. Antifungal drug resistance: an update. Eur J Hosp Pharm Sci Pract. 2022;29:109-12.

Reddy GKK, Padmavathi AR, Nancharaiah YV. Fungal infections: Pathogenesis, antifungals and alternate treatment approaches. Curr Res Microb Sci. 2022;3:100137.

Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med. 2012;125(Suppl. 1):S3-13.

Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E, et al. Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nat Microbiol. 2022;7:663-74.

Zhou D, Korfanty GA, Mo M, Wang R, Li X, Li H, et al. Extensive genetic diversity and widespread azole resistance in greenhouse populations of Aspergillus fumigatus in Yunnan, China. mSphere. 2021;6:e00066-21.

Osherov N, Kontoyiannis DP. The anti-Aspergillus drug pipeline: Is the glass half full or empty? Med Mycol. 2017;55:118-24.

Perfect JR. The antifungal pipeline: a reality check. Nat Rev Drug Discov. 2017;16:603-16.

Hoenigl M, Sprute R, Egger M, Arastehfar A, Cornely OA, Krause R, et al. The antifungal pipeline: Fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin. Drugs. 2021;81:1703-29.

Denning DW, Bromley MJ. Infectious disease. How to bolster the antifungal pipeline. Science. 2015;347:1414-6.

Niazi-Ali S, Atherton GT, Walczak M, Denning DW. Drug-drug interaction database for safe prescribing of systemic antifungal agents. Ther Adv Infectious Dis. 2021;8:19.

Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med. 2021;9:e77.

Deepe GS. Outbreaks of histoplasmosis: The spores set sail. PLoS Pathog. 2018;14:e1007213.

Armstrong PA, Beard JD, Bonilla L, Arboleda N, Lindsley MD, Chae SR, et al. Outbreak of severe histoplasmosis among tunnel workers-Dominican Republic, 2015. Clin Infect Dis. 2018;66:1550-7.

Andes D, Casadevall A. Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitis. Fungal Genet Biol. 2013;61:143-5.

Etienne KA, Roe CC, Smith RM, Vallabhaneni S, Duarte C, Escadón P, et al. Wholegenome sequencing to determine origin of multinational outbreak of Sarocladium kiliense bloodstream infections. Emerg Infect Dis. 2016;22:476-81.

Naranjo-Ortiz MA, Gabaldón T. Fungal evolution: Diversity, taxonomy and phylogeny of the fungi. Biol Rev Camb Philos Soc. 2019;94:2101-37.

Spatafora JW, Aime MC, Grigoriev IV, Martin F, Stajich JE, Blackwell M. The fungal tree of life: From molecular systematics to genome-scale phylogenies. Microbiol Spectr. 2017;5.

No authors listed. Stop neglecting fungi. Nat Microbiol. 2017;2:17120.

Gow NAR, Amin T, McArdle K, Brown AJP, Brown GD, Warris A, et al. Strategic research funding: A success story for medical mycology. Trends Microbiol. 2018;26:811-3.

World Health Organization. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. Geneva: World Health Organization; 2017.

Cómo citar
Gómez BL, Escandón P. Las infecciones fúngicas: una amenaza creciente. biomedica [Internet]. 31 de agosto de 2023 [citado 29 de mayo de 2024];43(Sp. 1):11-6. Disponible en:

Algunos artículos similares:



Estadísticas de artículo
Vistas de resúmenes
Vistas de PDF
Descargas de PDF
Vistas de HTML
Otras vistas
Crossref Cited-by logo
QR Code